Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoWhat Do Annual Metrics Say? Moderna stock went public at 23 in late 2018. In 2020, shares rocketed...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 4 days agoWedbush analyst Laura Chico slashed her price target on Aerovatestock to 3 from 41, calling the...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day...
Benzinga· 3 days agoShares of Quantum Corporation QMCO fell sharply during Tuesday's session after the company reported...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.